EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of Hyperoxia and Antioxidants on Mortality, Hospital Admissions, and Myocardial Infarction After Noncardiac Surgery: 1‐Year Follow‐Up of a Randomized Controlled Trial

Frederik C Loft, Cecilie Holse, Eske K Aasvang, Morten Vester-Andersen, Lars S Rasmussen iD, Lars N Jørgensen, Christian S Meyhoff iD

Acta Anaesthesiologica Scandinavica · 2025

DOI: 10.1111/aas.70118 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2025. Verfasst von Frederik C Loft und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia and Intensive Care, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Myocardial Infarction, Antioxidants, Hyperoxia, Postoperative Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dansk Selskab for Anæstesiologi og Intensiv Medicin, the Bispebjerg and Frederiksberg Hospital Research Foundation, Scandinavian Society of Anaesthesiology and Intensive Care Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Perioperative hyperoxia may be associated with increased long‐term mortality, whereas perioperative antioxidants may be associated with reduced long‐term mortality. This study aimed to determine if high perioperative inspiratory oxygen fraction (FiO 2 ) (0.80) compared with normal FiO 2 (0.30) would increase mortality, hospital admissions, and myocardial infarction (MI) within 1 year after surgery, and whether antioxidants compared with placebo would reduce this.

Methods

This was the preplanned 1‐year follow‐up of 600 patients with cardiovascular risk factors, scheduled for noncardiac surgery. They were randomized in a 2 × 2 factorial design to perioperative FiO 2 of 0.80 or 0.30 and to receive antioxidants (vitamin C and N‐acetylcysteine) or matching placebo. The primary 1‐year outcome was all‐cause mortality, and secondary 1‐year outcomes were one or more hospital admissions and MIs, respectively. All outcomes were assessed using medical records and analyzed with the Cox proportional hazards model.

Results

Follow‐up was completed for 594 patients (99%). Twenty‐five of 298 patients (8.4%) allocated to FiO 2 of 0.80 died within 1 year as compared with 17 out of 296 (5.7%) allocated to FiO 2 of 0.30, HR 1.46 (95% CI, 0.79–2.70), p = 0.23. A total of 260 patients had one or more hospital admissions (44%), and seven patients had MI (1.2%) with no significant difference when comparing FiO 2 of 0.80 with 0.30. Antioxidants had a HR of 0.98 (95% CI, 0.54–1.80), p = 0.96 for all‐cause mortality vs. placebo. The interaction between the FiO 2 and antioxidant administration was statistically significant ( p = 0.04) with fatalities overrepresented in patients given 80% oxygen and placebo.

Conclusions

Differences in all‐cause mortality, hospital admission, or MI were not statistically significant at 1‐year follow‐up for either oxygen fractions or antioxidant administration in patients undergoing major noncardiac surgery. Editorial Comment In this preplanned long‐term study of the VIXIE trial, no differences in total mortality, hospitalization, or myocardial infarction were found for oxygen fractions of 0.80 compared to 0.30 or antioxidant administration compared to placebo. Interestingly, the study showed a higher rate of fatalities with 80% oxygen which appeared only to be present in patients not given the antioxidant intervention, but this is hypothesis‐generating and needs to be further investigated in new clinical trials. Trial Registration: Clinicaltrials.gov identifier: NCT03494387

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionAntioxidantsHyperoxiaPostoperative ComplicationsSurgical Procedures, OperativeHumansMaleFemaleAgedMiddle AgedFollow-Up StudiesHospitalizationAscorbic AcidAcetylcysteineOxygen Inhalation TherapyDouble-Blind Method

Substanzen

AntioxidantsAscorbic AcidAcetylcysteine

Autor:innen und Institutionen

  • Department of Anaesthesia and Intensive Care, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  • Novo Nordisk, Søborg, Denmark.
  • Department of Anaesthesia, Center of Cancer and Organ Dysfunction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Herlev Anaesthesia Critical and Emergency Care Science Unit, Department of Anaesthesiology, Copenhagen University Hospital - Herlev and Gentofte Hospital, Copenhagen, Denmark.
  • Personnel Agency, Danish Ministry of Defence, Copenhagen, Denmark.

ORCID-Profile: Lars S Rasmussen, Christian S Meyhoff

Förderung

  • Dansk Selskab for Anæstesiologi og Intensiv Medicin
  • the Bispebjerg and Frederiksberg Hospital Research Foundation
  • Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Zitieren

APA

Loft, F. C., Holse, C., Aasvang, E. K., Vester-Andersen, M., Rasmussen, L. S., Jørgensen, L. N., & Meyhoff, C. S. (2025). Effects of Hyperoxia and Antioxidants on Mortality, Hospital Admissions, and Myocardial Infarction After Noncardiac Surgery: 1‐Year Follow‐Up of a Randomized Controlled Trial. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.70118

Vancouver

Loft FC, Holse C, Aasvang EK, Vester-Andersen M, Rasmussen LS, Jørgensen LN, et al. Effects of Hyperoxia and Antioxidants on Mortality, Hospital Admissions, and Myocardial Infarction After Noncardiac Surgery: 1‐Year Follow‐Up of a Randomized Controlled Trial. Acta Anaesthesiologica Scandinavica. 2025. doi:10.1111/aas.70118

BibTeX
@article{Loft2025,
  author = {Loft, Frederik C and Holse, Cecilie and Aasvang, Eske K and Vester-Andersen, Morten and Rasmussen, Lars S and Jørgensen, Lars N and Meyhoff, Christian S},
  title = {Effects of Hyperoxia and Antioxidants on Mortality, Hospital Admissions, and Myocardial Infarction After Noncardiac Surgery: 1‐Year Follow‐Up of a Randomized Controlled Trial},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2025},
  doi = {10.1111/aas.70118}
}
Kostenlos starten →